Showing 8361-8370 of 10903 results for "".
Psoriasis Risk Factors and Comorbidities
https://practicaldermatology.com/topics/psoriasis/psoriasis-risk-factors-and-comorbidities/19650/Ronald Prussick, MD outlines known risk factors for developing psoriasis, such as genetic factors, smoking, alcohol consumption, and increased BMI, and recent studies that confirm these risks. He also shares data on comorbidities, including the patients with psoriasis are more prone to pathologic frUpdates from ASDS and ISHRS
https://practicaldermatology.com/videos/dermwire-tv/-dermwiretv-updates-from-asds-and-ishrs/18217/The Annual meeting of the American Society for Dermatologic Surgery (ASDS) gathered experts in dermatologic surgery in Phoenix. Joel L. Cohen, MD and Shannon Humphrey, MD, who received the 2018 ASDS Award for Outstanding Service, discussed effective cosmetic consults. Diane Berson, MD addressed bothTherapeutic Advancements in Dermatology
https://practicaldermatology.com/topics/psoriasis/therapeutic-advancements-in-dermatology/18347/What therapeutic innovations define the specialty of dermatology? From significant strides in managing STDs and battling skin cancer to the harnessing of retinoids and the integration of biologics, dermatology has remained at the leading edge of medicine. Take a look at the specialty's top advancemeTwo Launches from Cutera, AmSpa Projections
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-two-launches-from-cutera-amspa-projections/18356/Cutera introduces two new devices to its laser and energy-based device offerings: Juliet laser represents Cutera's first entry into the women's health segment of the aesthetics market; Secret RF is a new fractional radio frequency microneedling device that effectively remodels collagen, improves milIs Your Financial Advisor Working for You
https://practicaldermatology.com/topics/practice-management/is-your-financial-advisor-working-for-you/18367/OJM Group Wealth Advisor, Andrew Taylor, CFP discusses the importance of working with an advisor with a "fiduciary" vs. "suitability" standard, and outlines other questions to ask when determining if your advisor is working in your best interest. Click here to request or download a free copy of WealUpdates from CSF 2017
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-updates-from-csf-2017/18371/Dermatologists and core cosmetic physicians shared new insights and reviewed the developments in clinical and cosmetic dermatology at the ninth annual Cosmetic Surgery Forum in Las Vegas. Matthew Zirwas, MD addressed interest in oral supplements to support skin health. Neurotoxin pioneer Nick Lowe,Revance Data, AD Updates, FDA Actions
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-revance-data-ad-updates-fda-actions/18463/A US District Court judge blocks Stratus Pharmaceuticals of Miami and Sonar Products of Carlstadt, NJ from selling substandard dermatological products. Newly identified mutations in a gene called CARD11 may lead to atopic dermatitis. Surprising new evidence suggests atopic dermatitis is associated wMid-Face Filler Pearls
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/mid-face-filler-pearls/18537/Shannon Humphrey, MD shares three pearls for avoiding the filler complication patients fear the most in the mid-face: unnatural results. You must have a plan, she says, to avoid treating the cheeks as an island rather than as part of the full face.Enhancing Your Procedures with Chemical Peels & Nutraceuticals
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/enhancing-your-procedures-with-chemical-peels-nutraceuticals/20274/Do chemical peels and nutraceuticals have a place in today's aesthetic practice? Yes, say Vivian Bucay, MD and Erin Gilbert, MD, PhD, speaking at Cosmetic Surgery Forum 2016 in Las Vegas. Get their pearls for successful integration. Get more info on Cosmetic Surgery Forum.Humphries to Valeant, Restylane Line Expands, 2016 Highlights
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-humphries-to-valeant-restylane-line-expands-2016-highlights/18709/The filler market in the US expands with FDA approval of Galderma's Restylane Refyne and Restalyne Define for the treatment of nasolabial folds in patients over the age of 21. The gels are manufactured with XpresHAn Technology, which allows a range of flexibility and support for varied patient needs